VISMODEGIB for Brain neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where VISMODEGIB was used for Brain neoplasm malignant.
Most Reported Side Effects for VISMODEGIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Muscle spasms | 1,937 | 23.8% | 24 | 110 |
| Alopecia | 1,330 | 16.4% | 28 | 81 |
| Ageusia | 958 | 11.8% | 7 | 49 |
| Fatigue | 899 | 11.1% | 20 | 78 |
| Dysgeusia | 706 | 8.7% | 18 | 40 |
| Weight decreased | 688 | 8.5% | 19 | 59 |
| Nausea | 669 | 8.2% | 8 | 72 |
| Decreased appetite | 662 | 8.1% | 21 | 69 |
| Death | 657 | 8.1% | 641 | 23 |
| Diarrhoea | 446 | 5.5% | 16 | 48 |
| Constipation | 361 | 4.4% | 3 | 31 |
| Off label use | 335 | 4.1% | 24 | 24 |
| Asthenia | 274 | 3.4% | 14 | 52 |
| Arthralgia | 264 | 3.3% | 0 | 20 |
| No adverse event | 247 | 3.0% | 1 | 0 |
Other Indications for VISMODEGIB
Basal cell carcinoma (5,329)
Product used for unknown indication (1,417)
Skin cancer (452)
Basal cell naevus syndrome (129)
Neoplasm malignant (124)
Congenital anomaly (54)
Medulloblastoma (52)
Squamous cell carcinoma of skin (42)
Malignant melanoma (38)
Neoplasm (36)
Other Drugs Used for Brain neoplasm malignant
PROCARBAZINE (2,283)
TEMOZOLOMIDE (2,202)
BEVACIZUMAB (740)
TRAMETINIB DIMETHYL SULFOXIDE (317)
LOMUSTINE (291)
THALIDOMIDE (195)
DABRAFENIB (189)
IVOSIDENIB (140)
SELINEXOR (136)
AVAPRITINIB (122)